Search Results

Here you will find the range of pharmaceutical products that we offer in the UK for immunodeficiency, haemophilia, and other rare and serious diseases.

https://www.cslbehring.co.uk/products/product-range

CSL Behring is a specialty biotherapeutics company that is committed to treating people with rare and serious medical conditions.

https://www.cslbehring.co.uk/products

CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.

https://www.cslbehring.co.uk/our-company

CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions.

https://www.cslbehring.co.uk/research-and-development

Product Name Idelvion 250 IU powder and solvent for solution for injection Active Ingredient Albutrepenonacog alfa (recombinant coagulation factor IX, albumin fusion protein) Composition One vial contains nominally 250 IU of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), (INN = albutrepenonacog alfa).

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/february-2024/idelvion-0224.pdf

Product Name Fibrogammin 250 IU powder and solvent for solution for injection or infusion Active Ingredient Factor XIII Composition Fibrogammin contains approximately 62.5 IU/ml (250 IU/4 ml) of human plasma coagulation factor XIII when reconstituted with 4 ml water for injection

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2024-update/product-info---fibrogammin-0424.pdf

Product Name Berinert 500 IU powder and solvent for solution for injection Active Ingredient C1-esterase inhibitor, human Composition Berinert 500 contains 50 IU/ml C1-esterase inhibitor after reconstitution with 10 ml water for injections

https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2024-update/product-info---berinert-0424.pdf

CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.

https://www.cslbehring.co.uk/products/regulatory-compliance

CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.

https://www.cslbehring.co.uk/terms-of-use

CSL Behring is committed to support Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they are designed to treat.

https://www.cslbehring.co.uk/research-and-development/iis